Worldquant Millennium Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Worldquant Millennium Advisors LLC

$13.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $36.1 Million - $39.5 Million	-88,622 Reduced 42.89%	117,983 $49.3 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $23.4 Million - $28 Million	68,295 Added 49.38%	206,605 $84.1 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $796,413 - $853,593	-2,355 Reduced 1.67%	138,310 $48.1 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $44 Million - $49.2 Million	139,912 Added 18580.61%	140,665 $49.5 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $24.8 Million - $28.3 Million	-87,529 Reduced 99.15%	753 $237,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $16.2 Million - $18.2 Million	56,520 Added 177.95%	88,282 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $6.31 Million - $7.04 Million	23,055 Added 264.79%	31,762 $9.2 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $2.05 Million - $2.55 Million	8,707 New	8,707 $2.45 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $21.7 Million - $27.4 Million	-122,737 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.49 Million - $2.79 Million	-13,726 Reduced 10.06%	122,737 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $5.88 Million - $6.93 Million	31,363 Added 29.84%	136,463 $27.5 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $2.02 Million - $2.36 Million	9,778 Added 10.26%	105,100 $22.6 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $261,529 - $310,071	1,023 Added 1.08%	95,322 $25.9 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $13.1 Million - $17.2 Million	58,172 Added 161.02%	94,299 $27.4 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $1.21 Million - $1.5 Million	-6,070 Reduced 14.38%	36,127 $8.6 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $23 Million - $30.9 Million	-137,889 Reduced 76.57%	42,197 $9.24 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $46.2 Million - $52 Million	-278,140 Reduced 60.7%	180,086 $30.5 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $10.5 Million - $12.2 Million	63,941 Added 16.22%	458,226 $84 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $6.68 Million - $7.94 Million	40,802 Added 11.54%	394,285 $72.5 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $13.1 Million - $16.6 Million	86,440 Added 32.37%	353,483 $58.6 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $16.2 Million - $18.6 Million	96,331 Added 56.43%	267,043 $51.5 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $24.9 Million - $29 Million	170,712 New	170,712 $29 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account